Search results
Bob's discount campaign
Politico· 7 hours agoShawn LaTourette said in a statement. The proposed rule to delist the bald eagle as endangered includes the osprey, which was considered threatened, as well. The proposal ...
Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 4 days agoIn February 2023, the company reported updated positive data from three cohorts of the Phase...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 8 hours agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively ...
Insurance barriers hinder access to screening as colon cancer rates rise
UPI· 6 days agoMore than 53,000 Americans are projected to die from colorectal cancer this year. Although...
Cruising Kitchens hit rock bottom, owner says, but not giving up
San Antonio Express-News· 1 day agoThe San Antonio builder of mobile kitchens already had an impressive roster of clients, including...
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are...
Lake Arrowhead Mountain News· 3 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Colon cancer rates are rising in young Americans, but insurance barriers are making screening harder
The Conversation via Yahoo News· 6 days agoThis meant patients would have had to pay out of pocket to cover the anesthesia needed for...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
The Business Journals· 5 days agoSummit Therapeutics Inc. investors sent the company's stock up 272% Thursday following the release...
Gena McCarthy’s UNConventional Entertainment Signs With Buchwald
Deadline Hollywood· 23 hours agoEXCLUSIVE: Gena McCarthy and her UNConventional Entertainment banner has new representation. The company has signed with Buchwald. This comes just over a year after the former ...
FDA delays decision on Dupixent in COPD; Summit makes a bold claim
BioPharma Dive via Yahoo Finance· 4 days agoRegeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over...